Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings (ONDS) Stock Today, November 20, 2025: Big Swings After $35 Million Combat Drone Deal and Share Authorization Vote

Ondas Holdings Inc. (NASDAQ: ONDS) — the autonomous drones and private wireless company — is having another turbulent session today as Wall Street digests a fresh $35 million combat robotics investment and a key shareholder vote that dramatically expands the company’s capacity to issue new shares. As of late trading on Thursday, November 20, 2025, ONDS is changing hands around…
20 November 2025
JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY Stock Today, November 20, 2025: 6% Rally After Earnings Beat, Dividend Hike and Strong Ad Growth

JOYY stock price today: a standout among social media names Shares of JOYY Inc. (NASDAQ: JOYY), the Singapore‑based owner of Bigo Live, Likee, Hago and imo, are sharply higher on Thursday after the company reported third‑quarter 2025 results, raised its dividend and guided to higher revenue in the coming quarter. As of roughly mid‑afternoon on November 20, 2025 (3:45 p.m.…
20 November 2025
Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax (ABVX) Stock Jumps on AstraZeneca Takeover Rumors: Outlook for November 20, 2025

Abivax SA (NASDAQ: ABVX), the French biotech behind the inflammatory bowel disease drug candidate obefazimod, is back on traders’ screens today as the stock spikes on fresh takeover chatter involving pharma giant AstraZeneca. As of mid‑afternoon U.S. trading on Thursday, November 20, 2025, ABVX stock is trading around $121.94, up roughly 8% from Wednesday’s close of $112.95. Intraday, shares have…
Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

Kulicke & Soffa (KLIC) Jumps 11% After Q4 2025 Earnings Beat and Upbeat 2026 Guidance

November 20, 2025 — KLIC stock update Kulicke & Soffa Industries, Inc. (NASDAQ: KLIC) is trading sharply higher on Thursday after the semiconductor assembly equipment maker delivered a better‑than‑expected fourth‑quarter report and a stronger outlook for early fiscal 2026. As of early afternoon trading on November 20, KLIC shares are around $39.23, up roughly 11% on the day, with an…
20 November 2025
1 991 992 993

Stock Market Today

  • Asian Market Value Picks Spotlight Undervalued Stocks Including Nanjing Leads Biolabs
    February 6, 2026, 12:10 AM EST. Asian markets show mixed trends with China's CSI 300 steady and Hong Kong's Hang Seng rising. Investors eye undervalued stocks amid volatility. Nanjing Leads Biolabs (HK$12.79 billion market cap) trades 16.7% below estimated fair value at HK$64.3, with forecasted revenue growth of 55.8% annually. Fast Track FDA designations could accelerate drug approvals, boosting future earnings despite current low revenue. Qingdao Baheal Medical also appears undervalued by 14.1% at CN¥23.93, with strong earnings growth projected at 29.6% per year. Other notable deep value stocks include Thai Coconut, Sino Medical Sciences, and Restar, trading at nearly 50% discounts to fair value. These picks emerge from a specialized cash flow-based screener focusing on Asian firms presenting potential market inefficiencies.
Go toTop